Call us at (800) 421-8453
Donate
  • Contact Us
  • Clinical Trial Finder
  • About Us
    • Who We Are & What We Do
    • Mission & Vision
    • History
    • National Staff
    • Board Members
    • MARAC Advisories
    • Financials and Accountability
    • Job Openings
    • 2023-2024 Impact Report
    • Brochures
      • Who We Are and What We Do
      • Gene Therapy
      • CHW Education and Training
  • Sickle Cell Disease
    • Definition
      • What is Sickle Cell Disease (SCD)?
      • What is Sickle Cell Trait (SCT)?
      • Complications & Treatments
      • Glossary
      • FAQs
    • Links & Resources
    • Get Connected
    • oneSCDVoice
    • Our Stories
    • COVID-19
      • Information and Resources
      • Template Letters
  • Gene Therapy
    • SCDAA Statement on Approval
    • Warrior FAQs
  • Clinical Trials
    • Clinical Trials 101
    • Clinical Trial Finder
    • SCD C.A.R.E.S. Consortium
  • Our Initiatives
    • SCDAA and MedicAlert Pilot Program
    • Clinical Trial Finder
    • Mental Health and Wellness
    • Community Health Worker Training
    • The P.O.W.E.R. ECHO Project
    • Leadership Academy
    • Donate Blood for Sickle Cell
    • National Sickle Cell Advocacy Network
    • Volunteer
  • Advocacy
    • Advocacy Days
    • Advocacy Resources
    • Ambassadors & Celebrity Champions
      • Ayana Johnson
      • Markus Golden
      • Dexter Darden
      • London Knight
      • Howard Woolley
    • Find Your Representative
    • Congressional Sickle Cell Caucus
    • National Sickle Cell Advocacy Network
  • Events
    • World Sickle Cell Day
    • Sickletini Happy Hour
    • SCDAA Warrior Walkathon
    • National Sickle Cell Awareness Month
    • Annual National Convention
      • Abstract Competition
    • P.O.W.E.R. ECHO Trainings
    • Masterclass
  • News
    • SCDAA in the Press
    • Sickle Cell News
    • Media Partnerships
      • HCPLive®
      • EBONY
      • EMERGE Woman Magazine
      • MONARCH Magazine
      • BLACKDOCTOR.ORG
  • Membership
    • Find Member Organizations
    • Become A Member Organization
    • Member Benefits
  • Donate
    • Donate Now
    • 50 Years Forward
    • Legacy Donation
    • Workplace Giving
    • Give from a Donor-Advised Fund
    • Give from an IRA
    • Give Cryptocurrency

Blog

Read More

NEW – Sickle Cell Disease and COVID-19: Provider Advisory

  • March 18, 2020
  • admin

Download Provider Advisory Download Sub-Saharan African Provider Advisory An Outline to Decrease Burden and Minimize Morbidity This document will be updated... Continue Reading

Read More

NEW – Health Alert for People with Sickle Cell Disease and their Caregivers

  • March 17, 2020
  • admin

DOWNLOAD PATIENT PDF     (Spanish Version) DOWNLOAD PATIENT SUB-SAHARAN AFRICAN PDF SHOW THIS TO YOUR MEDICAL PROVIDERS TO HELP THEM HELP... Continue Reading

Read More

ASH and FDA Unveil New Recommendations to Guide Clinical Development of Sickle Cell Disease Therapies

  • December 13, 2019
  • admin

Joint FDA/ASH Led Initiative Highlights Importance of Using Patient Reported Outcomes and Biomarkers in Clinical Trials to Advance SCD Therapies (WASHINGTON,... Continue Reading

Read More

GBT’s Oxbryta™ (voxelotor) tablets is approved for the treatment of sickle cell disease

  • December 3, 2019
  • admin

Oxbryta™ (voxelotor) tablets Now Approved On behalf of GBT, we are happy to share that Oxbryta (pronounced ox-brye-ta) is now approved... Continue Reading

CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data

  • November 19, 2019
  • admin

Nov 19, 2019 CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9... Continue Reading

Read More

Novartis Adakveo approved by FDA for Sickle Cell Disease

  • November 16, 2019
  • admin

New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease Sickle... Continue Reading

Read More

Donate Blood to Support Sickle Cell Patients

  • September 10, 2019
  • admin

September is Sickle Cell Awareness Month; Red Cross blood and platelet donations needed for patients This school year students battling sickle... Continue Reading

GBT and SCDAA to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference

  • September 5, 2019
  • admin

GlobalBlood Therapeutics, Inc. (GBT) (NASDAQ: GBT) and the Sickle Cell Disease Association of America, Inc. (SCDAA) announced that they will host... Continue Reading

Read More

SCDAA Forms International Media Partnership to Spread SCD Awareness

  • July 16, 2019
  • admin

New International Media Partnership Will Enhance Awareness Efforts and Increase Awareness about Sickle Cell Disease and Sickle Cell Trait Sickle Cell... Continue Reading

Read More

SCDAA Partners with The Pain Community to Support the Sickle Cell Community by Providing Comprehensive Integrative Pain Management Educational Information

  • July 11, 2019
  • admin

Sickle Cell Disease Association of America, Inc. (SCDAA) and The Pain Community are proud to announce a new partnership that will... Continue Reading

  • ←
  • 1
  • 2
  • 3
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • →

CATEGORIES

  • CMO Speaks
  • MARAC Statements
  • News
  • Uncategorized

Archives

Sickle Cell Disease Association of America Inc. Seal of Transparency

Quick Links

  • About Us
  • Donate
  • Newsroom
  • Events
  • Membership
  • Initiatives
  • Site Map
  • Disclaimer
  • Privacy

Sign up for updates!

Get news from Sickle Cell Disease Association of America in your inbox.

Terms and conditions

Contact Us

Address:
7240 Parkway Drive, Suite 180
Hanover, MD 21076

Phone:
410.528.1555 (office)
410.528.1495 (fax)
800.421.8453 (toll-free)

Email:
info@sicklecelldisease.org

Copyright ©2021 Sickle Cell Disease Association of America, Inc - All rights reserved.